Our Mission
- We provide the highest quality of In-Vitro Diagnostics reagents for all over the world.
- Customers’ success is our business.
Our Company
ACTIF Japan was established in Tokyo in 2014.
We develop, distribute and manufacture worldwide In-Vitro Diagnostics for clinical and research applications on OEM basis. Diabetes; HbA1c reagent is the highest quality all over the world. Rheumatism; MMP3 is a new prognostic and activity marker for rheumatoid arthritis & prognosis, various characteristic ELISA kits and Antibodies, and other significant products in the wide-ranging field.
Business Policy
Partners worldwide is very important for us. Attractive distributors and suppliers are most welcome for us all the time. We are looking forward to having business alliance. Also, we strive to provide our customers with the highest quality and most reliable products, and services.
Quality Policy
Our QMS is built upon a Quality Policy aligned with our customer expectations: ACTIF will earn customer loyalty by providing trusted answers through continuous improvement of products, services, and interactions of the highest quality and greatest value.
QC Resources of Manufacturer
- ISO13485 Certificate
- HbA1c — NGSP Certificate
Company Information
| Corporate name | ACTIF CORPORATION |
|---|---|
| Head Office | 3-27 Grand Terrace 501, Kyodo, Setagaya-ku, Tokyo 1560052 JAPAN TEL&FAX: +81(0)3-5934-3601 |
| Representative Managing Director |
Takayuki SAKAMACHI |
| Incorporation | February/2014 |
| The substance of the business |
Production and Distribution of IVD (In-Vitro Diagnostics) reagents for the world-wide. |
Please feel free to ask me.+81(0)3-5934-3601Open Mon.-Fri. eleven am to six pm.
Sat. and Sun. and holidays are closed.